Pharma's Almanac TV
PA TV
Your Name
Your Email
Manage Account
Sign Out
Sign In
Register
Follow the Journey
Companies On The Road
Arcadis DPS Group
C2 Pharma
CAI
EcoLab
Environmental Systems Corporation
Federal Equipment Company
Globyz Biopharma Services
Grifols
Integrity
Nu-Tek BioSciences
PHARMALEX
Waters Corporation
Follow the Completed Journey
Companies On The Road
Follow The Artist
ABS
aCGT Vector
Alconox Inc.
Andelyn Biosciences
Arranta Bio
Avid Bioservices
BDD
BIOVECTRA
DPS Group
Dynamk Capital
Environmental Systems Corporation
Federal Equipment Company
Genesis AEC
Globyz Biopharma Services
Grifols Partnership
IDT Biologika
Inceptor Bio
IPS-Integrated Project Services
Kineticos Life Sciences
MilliporeSigma
Montana BioScience Alliance
Olon
Rentschler Biopharma
SanaClis
Scorpion Biological Services
Secant Group
Tapemark
VITRONIC
Follow the Completed Journey
Companies We've Met
AES Clean Technology
Altis Biosystems
Arranta Bio
Avara Pharmaceutical Services
Avid Bioservices
BioVectra
Centaur BPS
Dynamk Capital
ECRI
Evolve Biologics
Federal Equipment Company
Globyz
Inceptor Bio
IPS-Integrated Project Services
Olon
Pii
Polpharma Biologics
PPD
RoosterBio
SanaClis
Sanofi AIS
SGD Pharma
SPI Pharma
TriRx Pharmaceutical Services
Yourway
Dashboard
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Magazine
Archive
Reports
Nice Insight Reports
2022 Sterile
2023 Cell & Gene Therapy
2023 mAb and Recombinant Protein
2024 API
2024 OSD
2024 ADC
2024 mRNA
2024 Mammalian Cell Culture
2024 Microbial Cell Culture
2024 Plasmids
2024 Gene Therapy
2024 Cell Therapy
2024 Sterile
Community
Company A to Z
Follow the Journey
Companies On The Road
Follow The Artist
Follow the Journey
Companies On The Road
More+
Staffing
Media Kit
Large Molecule
253 Articles Available
1
11
Can't find what you're looking for? Try our
advanced search
.
Outsourced Manufacturing
A Closer Look at Small Molecule Drug Substance and Drug Product Manufacturing
PAO-03-24-NI-02
Analytical Method Development
Harnessing Biosimilar Experience in Support of CDMO Clients: Rapid, Effective and Tailored Analytical Method Development
PAO-03-24-CL-09
Bispecific Antibodies
Accelerating the Development and Production of High-Quality Bispecific Antibodies
PAO-03-24-CL-01
Biologics Formulation
Successful Formulation Development for Biologics Using a Unique Biophysical Prediction and Screening Platform
PAO-02-24-CL-02
Recombinant Antibody
Recombinant Antibody Technology is Crucial to Past and Future Success in Biopharma
PAO-01-24-CL-4
Glycosylation
S-Glyn™ : Optimizing N-Glycan Profiles and their Effector Functions Using a Design-of-Experiments Approach
PAO-12-23-CL-06
Strategic Partnership
Samsung Biologics and Kurma Partners Announce Strategic Partnership for Development and Manufacturing of Biologics for Kurma’s Portfolio Companies
PR-M10-23-06
Insect Cell Expression
Innovations in Baculovirus–Insect Cell Expression Systems
PAO-09-23-CL-01
Quality Culture
Does Your Biologics CDMO Truly Have a Culture of Quality?
PAO-07-23-CL-07
R&D
Integrating Digital Solutions to Streamline Biopharma Operations
PAO-07-23-CL-06
Leadership
Wheeler Bio Appoints Dr. Stewart McNaull as Chief Business Officer
PR-M06-23-02
Distribution
Redefining Innovation and Growth in Pharmaceutical Distribution
PAO-06-23-CL-03
Biomanufacturing
Biologics Outsourcing: Decision Drivers and Key Considerations
PAO-04-23-CL-01
Tumor Microenvironment
Harnessing the Power of the Tumor Microenvironment with First-in-Class Therapies
PAO-03-23-CL-01
Scale-Up
Scale-Up Expertise to Support Your Biologics Life Cycle
PAO-02-23-CL-06
Antibody Production
From Llamas to Yeast: Producing Functional Therapeutic Antibody Fragments in Saccharomyces cerevisiae
PAO-01-23-CL-05
Biomanufacturing
An Experienced CDMO Can Be a Differentiator in the Rapidly Growing Biologics Market
PAO-01-23-CL-04
Anti-Idiotype Antibodies
Rapid Supply of Anti-Idiotype Antibodies Facilitates Preclinical and Clinical Antibody-Based Drug Development
PAO-01-23-CL-01
Artificial Intelligence in Antibody Design
Accelerated and Cost-Effective Antibody Design Using Artificial Intelligence
PAO-11-022-CL-15
Biomanufacturing
New Name, Same Expertise: Goodwin Biotechnology is Becoming GBI!
PAO-11-022-CL-11
Multispecific Antibodies
Optimized Multispecific Antibody Design, Development, and Manufacturing
PAO-08-022-CL-04
Cell Line Development
Wheeler Bio Integrates the Solentim® Ecosystem by Advanced Instruments to Deliver the Highest Level of Consistency Across Their Cell Line Development Workflow
PR-M06-22-04
Recombinant Antibodies
Taking a Customer-Focused Approach to Custom Antibody Development and Manufacturing
PAO-04-022-CL-01
Oncology Collaboration
Tegmine Therapeutics Announces Collaboration with Alloy Therapeutics to Advance Solid Tumor Treatment
PR-M04-22-03
1
11
»